Last reviewed · How we verify

guided injection of mepivacaine

Complejo Hospitalario Universitario de Granada · FDA-approved active Small molecule

guided injection of mepivacaine is a Local anesthetic (amide) Small molecule drug developed by Complejo Hospitalario Universitario de Granada. It is currently FDA-approved for Local anesthesia via guided injection for regional nerve blocks and infiltration anesthesia. Also known as: guided perineural injection.

Mepivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission.

Mepivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission. Used for Local anesthesia via guided injection for regional nerve blocks and infiltration anesthesia.

At a glance

Generic nameguided injection of mepivacaine
Also known asguided perineural injection
SponsorComplejo Hospitalario Universitario de Granada
Drug classLocal anesthetic (amide)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia / Pain Management
PhaseFDA-approved

Mechanism of action

Mepivacaine is an amide-type local anesthetic that reversibly inhibits sodium influx into nerve fibers, thereby preventing depolarization and conduction of action potentials. When administered via guided injection (likely ultrasound or fluoroscopy-guided), it achieves targeted anesthesia at specific anatomical sites. The guided delivery approach enhances precision and efficacy while potentially reducing systemic exposure.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about guided injection of mepivacaine

What is guided injection of mepivacaine?

guided injection of mepivacaine is a Local anesthetic (amide) drug developed by Complejo Hospitalario Universitario de Granada, indicated for Local anesthesia via guided injection for regional nerve blocks and infiltration anesthesia.

How does guided injection of mepivacaine work?

Mepivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission.

What is guided injection of mepivacaine used for?

guided injection of mepivacaine is indicated for Local anesthesia via guided injection for regional nerve blocks and infiltration anesthesia.

Who makes guided injection of mepivacaine?

guided injection of mepivacaine is developed and marketed by Complejo Hospitalario Universitario de Granada (see full Complejo Hospitalario Universitario de Granada pipeline at /company/complejo-hospitalario-universitario-de-granada).

Is guided injection of mepivacaine also known as anything else?

guided injection of mepivacaine is also known as guided perineural injection.

What drug class is guided injection of mepivacaine in?

guided injection of mepivacaine belongs to the Local anesthetic (amide) class. See all Local anesthetic (amide) drugs at /class/local-anesthetic-amide.

What development phase is guided injection of mepivacaine in?

guided injection of mepivacaine is FDA-approved (marketed).

What are the side effects of guided injection of mepivacaine?

Common side effects of guided injection of mepivacaine include Injection site reactions (pain, erythema), Transient paresthesia, Systemic toxicity (if absorbed in excess), Allergic reactions (rare with amides).

What does guided injection of mepivacaine target?

guided injection of mepivacaine targets Voltage-gated sodium channels and is a Local anesthetic (amide).

Related